Clinical Trial: Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL




Official Title: A Phase 2a Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Study of Intravenous ANX005 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Brief Summary: This study is a multi-center, open-label study of intravenous (IV) ANX005 in participants with ALS.